No published evidence was available as to the roles of the remaining eight underexpressed gene signatures (CHST9, CSDC2, ENHO, FERMT1, IGFN1, LINC00836, MGAT4C and SHANK2) regarding glioma pathogenesis or prognosis. This evidence concerns the gene CSDC2 and central nervous system cancer.